SPENCER TOWNSEND: Open Payments
NPI 1780889477 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,170 in 55 payments from 13 companies in 2025. Trend: 2023 $466 · 2024 $1,144 · 2025 $1,170
Food & beverage: $1,096Education: $74
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $217 |
| GlaxoSmithKline, LLC. | 11 | $180 |
| Regeneron Healthcare Solutions, Inc. | 4 | $145 |
| CSL Behring | 6 | $111 |
| Amgen Inc. | 5 | $111 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $94 |
| AstraZeneca Pharmaceuticals LP | 4 | $87 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Ionis Pharmaceuticals, Inc. | 2 | $47 |
| BioCryst US Sales Co., LLC | 1 | $35 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, NEFFY, TRELEGY ELLIPTA, Andembry, DAWNZERA, FASENRA.
Industry payments across CA — which companies pay providers there.
